FinTech in Focus — January 11, 2021
ViewNewsletter
Ep. 119: Revolutionary, with UC Berkeley's Jennifer Doudna
“Diagnosis goes hand in hand with vaccination, and of course with therapies as well. What CRISPR is doing is providing for rapid turnaround testing at a lower cost and higher throughput than we've had with other technologies. We'll see that...
Revolutionary, with UC Berkeley's Jennifer Doudna
Future of Aging - January 2021
ViewNewsletter
Ep. 118: Core Values, with Google Cloud's Thomas Kurian
“The process of digitization – whether that was e-commerce in retail, or online gaming for media, online streaming in the media business, digital platforms for the public sector – was already underway. But it enormously accelerated with the...
Core Values, with Google Cloud's Thomas Kurian
Ep. 116: Encore, with Sherry Lansing
“When we get out of this pandemic, I suspect people are going to want to flock to the movie theaters. But they're also going to say, I still want my content delivered. So, the movie industry is going to face a decision. Do they offer it...
Encore, with Sherry Lansing
Ep. 115: New Heroes, with NIH's Francis Collins
“It has been a year of terrible tragedy. … And yet, it's also been a year of heroism: the first responders, the healthcare providers, putting themselves at risk to try to help those who are suffering. But I also think there are heroes that...
New Heroes, with NIH's Francis Collins
Ep. 114: Collaborating to Beat COVID: A Conversation with Leaders from Health and Bioscience
“Are we willing to do for life sciences and global defense what we were willing to do for the financial environment in the 2008 financial crisis? Because if you compare the trillions of dollars committed to stabilize the financial systems...
Collaborating to Beat COVID: A Conversation with Leaders from Health and Bioscience
FinTech in Focus — December 21, 2020
ViewNewsletter
Ep. 113: "To Boldly Go," with Operation Warp Speed's Moncef Slaoui
“The efficacy of these vaccines is spectacular. It's 95%, the same whether you are an African-American or Hispanic or over 65 years old. … Remarkably, these two vaccines developed in different companies, two different continents, give...
"To Boldly Go," with Operation Warp Speed's Moncef Slaoui
Ep. 112: Speed of Science, with Pfizer’s Albert Bourla and Johnson & Johnson’s Alex Gorsky
“I think history has shown us to have major leaps forward almost after every crisis. Whether it's a war, a natural disaster, or frankly a big challenge such as going to the moon, these kinds of inflection points force us to go in new...
Speed of Science, with Pfizer’s Albert Bourla and Johnson & Johnson’s Alex Gorsky